SCHEMBL18274746

SCHEMBL18274746

CN1CCN(CCNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(Cc5cc(Cl)ccc5-c5ccccc5)CC4)cc3Oc3ccccc3)cc2[N+](=O)[O-])CC1

nearest known ligand 0.89

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 5/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958620 0.94 BCL2 (0.80) BCL2
SCHEMBL1957629 0.91 BCL2 (0.86) BCL2
SCHEMBL18274762 0.90 BCL2 (0.66) BCL2
SCHEMBL1957757 0.87 BCL2 (0.78) BCL2
SCHEMBL1957772 0.87 BCL2 (0.87) BCL2
SCHEMBL1957770 0.86 BCL2 (0.90) BCL2
SCHEMBL1957559 0.86 BCL2 (0.84) BCL2
SCHEMBL1956365 0.86 BCL2 (0.76) BCL2
SCHEMBL1956026 0.86 BCL2 (0.85) BCL2
SCHEMBL1957374 0.85 BCL2 (0.97) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3101019-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES AbbVie Inc. (US) 2016-12-07 — — EP claimed
Send feedback